The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

The blood test was cleared for use in people age 55 and older who exhibit signs and symptoms of the disease. The FDA said ...

The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance ...

The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal ...

The USFDA has approved the first-ever blood test to help diagnose Alzheimer's disease, offering a faster, less invasive, and ...

Since Alzheimer's disease affects over 7 million people in the U.S., potentially doubling to 14 million by 2050, earlier ...

Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...

Possible to Get an Alzheimer’s Blood Test in Your Doctor’s Office. The FDA has just granted expedited approval for the ...

The Global Alzheimer's Platform Foundation® (GAP) applauds the FDA's clearance of the first blood test to diagnose ...

This revolutionary tool, named the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio, marks a shift from traditional, often burdensome testing methods like PET scans and spinal taps to a minimally ...